Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect of Renalytix plc from 30 Sep 2021 to 30 Sep 2024
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
- Summary
-
Renalytix plc quarterly and annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect in USD history and change rate from 30 Sep 2021 to 30 Sep 2024.
- Renalytix plc Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending 30 Sep 2024 was $3,771,000, a 65% increase year-over-year.
- Renalytix plc annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2024 was $20,002,000, a 20% decline from 2023.
- Renalytix plc annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2023 was $16,651,000, a 30% increase from 2022.
- Source SEC data
- View on sec.gov
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Quarterly Change (%)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Annual (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Annual Change (%)
Renalytix plc Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 2024 | $3,771,000 | +$7,020,000 | +65% | 01 Jul 2024 | 30 Sep 2024 | 10-Q | 19 Nov 2024 | 2025 | Q1 | |
| Q3 2023 | $10,791,000 | -$498,000 | -4.8% | 01 Jul 2023 | 30 Sep 2023 | 10-Q | 19 Nov 2024 | 2025 | Q1 | |
| Q3 2022 | $10,293,000 | +$509,000 | +4.7% | 01 Jul 2022 | 30 Sep 2022 | 10-Q | 14 Nov 2023 | 2024 | Q1 | |
| Q3 2021 | $10,802,000 | 01 Jul 2021 | 30 Sep 2021 | 6-K | 30 Nov 2022 |
Renalytix plc Annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2024 | $20,002,000 | -$3,351,000 | -20% | 01 Jul 2023 | 30 Jun 2024 | 10-K | 30 Sep 2024 | 2024 | FY |
| 2023 | $16,651,000 | +$7,144,000 | +30% | 01 Jul 2022 | 30 Jun 2023 | 10-K | 30 Sep 2024 | 2024 | FY |
| 2022 | $23,795,000 | 01 Jul 2021 | 30 Jun 2022 | 10-K | 28 Sep 2023 | 2023 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.